|As i've been dozing off these days,i'd thought change my armchair.
Searched through the cellar and pulled out a
red leather quilted dorset captains chair.
i hope i don't get sea sick|
Red wine health locations found
Procyanidin levels depend on how the wine is made
Those seeking a longevity-boosting tipple should turn their attention to red wines from Sardinia and south-west France, a study concludes.
UK researchers discovered chemicals called procyanidins were responsible for red wine's well-documented heart-protecting effect.
And they found traditionally made wines from these areas had more procyanidins than wines in other parts of the world.
The research is published in the journal Nature.
There is a 19th century expression: 'A man is only as old as his arteries'
Professor Roger Corder, Queen Mary, University of London
Previous studies have revealed regular, moderate consumption of red wine is linked to a reduced risk of heart disease and lower mortality.
A class of chemicals called polyphenols, of which there are many varieties, are thought to be responsible.
Using endothelial cells (cells that line the vascular system), the researchers pinpointed polyphenols called procyanidins as those that provided the most potent protective effect.
They then tested red wines from around the world to measure their levels of procyanidins, including wines from Nuoro province in Sardinia and the Gers region of the Midi-Pyrenees in south-west France, areas famous for their population's longevity.
They discovered wines from these regions had on average between two and four times the level of procyanidin compared with wines from countries including Spain, Australia, South America and the US.
Professor Roger Corder, from the William Harvey Research Institute, at Queen Mary, University of London, said: "There is a 19th Century expression: 'A man is only as old as his arteries', which can be taken to mean that those with the healthiest arteries live longer.
"So it was of great interest to us when we found both in Sardinia and in south-west France that the wines made in these in areas had higher levels of procyanidins."
The researchers believe the way that wines are made is the key.
In traditional wine making, said Professor Corder, grapes have a three to four week fermentation period, allowing for full extraction of the chemical from the skin and the seed.
Those who do enjoy a tipple should keep within the recommended levels
Cathy Ross, British Heart Foundation
Modern-style wines are only fermented for a week, resulting in little or no procyanidin.
He added that the grape was also important and the tannat, cabernet sauvignon and Nebbiolo grapes made procyanidin-rich wines.
Professor Corder said: "The traditional production methods used in Sardinia and south-western France ensure that the beneficial compounds, procyanidins, are efficiently extracted.
"This may explain the strong association between consumption of traditional tannic wines with overall wellbeing, reflected in greater longevity."
Cathy Ross, cardiac nurse at the British Heart Foundation (BHF), said: "While we have known for some time that a moderate amount of alcohol can help to reduce your risk of developing heart disease, we would not recommend anyone to start drinking. Those who do enjoy a tipple should keep within the recommended levels.
"There are better ways to reduce your risk. Stopping smoking, eating a healthy diet low in saturated fat and getting at least 30mins of exercise five times a week will all help your heart."
|Where can I get some? - without getting too drunk.|
|funny old week,forgot which day it was.
suppose i best be getting to the Tripe Fair over yonder.
Reduced holding in Syngenta
but increased holdings in Total,Novartis and Sanofi.
Silly me thought i was getting an additional bargain with Total,
but alas it had gone ex divi.
will be a bit more attentive next time.
i guess this armchair is too snudge
enjoy your weekend
ps might try Tripe a la Curry
Curried mogodo (tripe)
1.50 kg tripe, cleaned, pre-cooked and cubed
5 ml salt
15 ml lemon juice
60 ml oil
20 ml curry powder
1 onion, chopped
1 garlic clove, chopped
2 carrots, peeled and diced
115 g (1 can) tomato paste
400 g (1 can) chopped tomatoes
30 ml sugar
Wash and rinse tripe thoroughly.
Place in cold water, and add salt and lemon juice.
Bring to the boil and simmer gently for 2 hours, or until tender.
To make sauce:
Heat oil and add curry powder, onion and garlic.
Sauté until transparent, then add remaining ingredients and simmer for 15 minutes.
Drain tripe and add to tomato sauce.
Cook for a further 20 minutes.
Serve hot with samp or maize rice.
|Sanofi-Aventis Veteran Set to Become R&D Head
By Jeanne Whalen
Word Count: 394 | Companies Featured in This Article: Sanofi-Aventis
When Gerard Le Fur takes over as chief executive of drug giant Sanofi-Aventis SA in January, he is expected to appoint company veteran Marc Cluzel to succeed him as head of research and development, people familiar with the situation say.
Sanofi's current chairman and chief executive, Jean-Francois Dehecq, announced in May that he would step down as CEO on Jan. 1, and that he was nominating Dr. Le Fur to take his place. Mr. Dehecq, who has led Sanofi ...
THE FULL WSJ.com ARTICLE IS ONLY AVAILABLE TO SUBSCRIBERS.
(He's having a doze in his favourite armchair. The one by the fireplace.)|
|these are quiet times|
|expect general market to nicely move up today.|
|its interesting sometimes when one asks a simple question
suddenly there's a frenzy and then all is still.
i remember many years ago catching a barracuda, only
to have it quickly disappear in a feeding frenzy
of blood scented mindless barracudas and then
all was still with me left with just the a small share.|
Hambi - 6 Nov'06 - 10:23 - 11250 of 11250
has anyone noticed that the 74.5p comes from a NPV analysis whereas in the bn the discoutned cash flow analysis gives a market valuation range of 102-117p per share (page 12)|
|V11SLR - 6 Nov'06 - 10:14 - 3311 of 3311
Interesting the way they've come up with the value.
Their DCF model over 10 years gives a fair value of 109p in a range of 102-117p and their NPV analysis over 20 years gives a fair value of 74.5p.|
|anotherguru - 6 Nov'06 - 10:11 - 3306 of 3308
AiM / Pharmaceuticals & Biotechnology / BPRG.L
Bridgewell Limited acts as broker and Nomad to BioProgress, and makes markets in
airPharma acquisition, SoluPol deal & fund raising
Over the last few months, BioProgress has continued to make substantial
progress in its new business strategy. This has been further bolstered by
recent acquisition of the airPharma assets, which will contribute to
branded product strategy and to the Rx-OTC switch strategy, which
management started to pursue with the acquisitions of Dexo and Segix. This
airPharma acquisition, in conjunction with the first BioProgress enabling
technology deal for SoluPol, means that BioProgress is now expected to show
substantial profit growth over the next few years. In light of these upgrades
to our forecasts, we are revising our market valuation range to £125.5m-
£172.0m or 74.5p-102.2p per share. We therefore retain our Buy rating.|
|markets are generally rising today,so might not buy shares to day.|
|today i see that bridgewell has come up
with a revised fair value for bprg of 74 to 102p
nice to see,but would to know the basis of valuation.|
|tried to get someone to give a decent valuation for bprg,
but only ended up getting filtered.|
|another heavy frost this morning.
that won't stop from go getting this weeks financial press.
Tonight we have deboned lamb shoulder marinated in whisky.
With small potatoes and a couple of bottles of fleurie for good measure.
remember red wine is good for stopping Ageing
enjoy your weekend all|
|just read that wine stops ageing.
ah i feel much better now.
|first heavy frost this season.
won't be venturing far from the armchair this morning.|
|thrown some wood on the fire.
cleared up the leaves
now off i go to feed the frogs.|
|SocGen Lowers Sanofi Target Price To EUR85.6
Thursday, November 02, 2006 5:49:39 AM ET
Dow Jones Newswires
0925 GMT [Dow Jones] Societe Generale lowers Sanofi-Aventis (SNY) target price to EUR85.6 from EUR90 based on a higher discount rate to take into account "risks and threats," following 3Q results. Target price is still substantially higher than the current share price, bank notes. Keeps its buy rating. Shares -0.8% at EUR66.20.(ACH)
|It appears to be a down Day today.
i've started to wonder whether there's a correlation between
temperture drops and share price drops.
The NE Wind doeth blow and we shall have snow.
Sunny and Blue Skys today however.
Feel like snuggling down into the Armchair.
Yet must pop out into the artic weather to buy and plant some Kiwi Fruit Climbers.
Enjoy your Day
I'll look in later.|